Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

Assays can provide a useful tool in determining the potential toxicity of drugs throughout the development cycle.


Keeping Toxicity to a Minimum

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Formulating fixed-dose combination drugs proves more complex than simply adding one ingredient to another. 

Characterizing APIs is Essential for Combo Drug Formulations

Researchers at the Technical University of Munich (TUM) have discovered a way of continuously and precisely dosing active agents using an oil-hydrogel mixture.


Researchers Discover Way of Continuously and Precisely Dosing Active Agents

Inhalation drug delivery company Vectura announces new organizational structure to drive innovation, customer focus, and growth.

Vectura Appoints Sharon Johnson Executive VP

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Consider equipment design, transfer systems, and maintenance when operating isolators for sterile manufacturing of pharmaceutical products.

Best Practices in Using Isolator Technology

Tim Roach is senior director of plant engineering at Recro Gainesville.

Careful design, planning, and record keeping are needed for cleaning and changeover in multiproduct pharmaceutical facilities.

Best Practices for Design and Operation of Multiproduct Manufacturing Facilities

GE Healthcare Life Sciences’ new facility for cell and gene processing supplies will be open in 2022. 

GE Builds Single-Use Kit Manufacturing Facility in Switzerland

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

Achieving effective manufacturing processes and sufficient capacity remains a top priority across a diversified biologic drug pipeline.


2020 Outlook for Biopharma Manufacturing

Generic pharmaceutical company, Hikma Pharmaceuticals, and biopharmaceutical company, Arecor, have entered into an exclusive agreement for the development and commercialization of a ready-to-use injectable medicine.


Hikma, Arecor Enter Exclusive Agreement for Ready-to-Use Medicine

FDA’s approval rate slowed, but the US agency is still ahead of its international counterparts in green-lighting new drugs for market.